Skip to main content
INTERNATIONAL BIOTECHNOLOGY TST PLC logo

INTERNATIONAL BIOTECHNOLOGY TST PLC — Investor Relations & Filings

Ticker · IBT ISIN · GB0004559349 LEI · 213800N1QUJ744P76D11 IL Financial and insurance activities
Open in API
Filings indexed 4,603 across all filing types
Latest filing 2026-03-23 Net Asset Value
Country GB United Kingdom
Listing IL IBT

About INTERNATIONAL BIOTECHNOLOGY TST PLC

https://www.ibtplc.com/

International Biotechnology Trust PLC is an investment trust that provides investors with access to the biotechnology and life sciences sectors. Its primary objective is to achieve long-term capital growth through an actively managed, diversified portfolio. The trust invests in a range of approximately 100 quoted and unquoted companies, from development to late-stage. A key aspect of its strategy is a focus on risk management, particularly ahead of significant company-specific events. Additionally, the trust aims to provide a reliable source of income, paying a biannual dividend equivalent to 4% of its net asset value.

Recent filings

Filing Released Lang Actions
Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document is an RNS announcement from International Biotechnology Trust plc that provides the unaudited Net Asset Value (NAV) per share for specific dates. It is clearly a regular NAV update for an investment trust, matching the definition of the Net Asset Value category.
2026-03-23 English
Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document is a short announcement from International Biotechnology Trust PLC regarding its Net Asset Value (NAV) per share as of March 19, 2026. It is distributed via the RNS (Regulatory News Service) and explicitly states the NAV figures in a table format. This fits the definition of a Net Asset Value (NAV) update for an investment fund.
2026-03-20 English
Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document is a short announcement from International Biotechnology Trust PLC providing the specific Net Asset Value (NAV) per share for a given date. It follows the standard format for NAV disclosures, which are regular updates for investment funds. It is not a full report, but a direct disclosure of the NAV figure, fitting the definition for the NAV category.
2026-03-19 English
Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document is a short announcement from International Biotechnology Trust PLC providing the specific Net Asset Value (NAV) per share for a given date. It follows the standard format for NAV disclosures, which are regular updates for investment funds. It is not a full report, but a direct disclosure of the NAV figure, fitting the definition for the NAV category.
2026-03-18 English
Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document is a short announcement from the London Stock Exchange's RNS service providing the Net Asset Value (NAV) per share for International Biotechnology Trust PLC as of March 16, 2026. It explicitly lists 'Net Asset Values' in the header and provides the specific NAV figures, which aligns perfectly with the definition for the NAV filing category.
2026-03-17 English
Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document is a short announcement from International Biotechnology Trust PLC providing the specific Net Asset Value (NAV) per share as of March 13, 2026. It follows the standard format for a NAV update, which is explicitly listed as a category in the provided definitions.
2026-03-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.